Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ) announced earnings for its full year that Increased, from the same period last year
The company's bottom line totaled RMB449.64 million, or RMB0.45 per share. This compares with RMB397.17 million, or RMB0.40 per share, last year.
The company's revenue for the period fell 6.0% to RMB3.758 billion from RMB4.000 billion last year.
Zhejiang Xianju Pharmaceutical Co.,Ltd. earnings at a glance (GAAP) :
-Earnings: RMB449.64 Mln. vs. RMB397.17 Mln. last year.-EPS: RMB0.45 vs. RMB0.40 last year.-Revenue: RMB3.758 Bln vs. RMB4.000 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.